News

CNET on MSN5h
OpenAI Launches HealthBench, a Dataset That Benchmarks Health Care AI Models
OpenAI, the creator of artificial intelligence chatbot ChatGPT, has a new open-source large language model called HealthBench ...
SoftBank, OpenAI’s $100B investment delayed due to tariffs: report
It’s been three months since SoftBank’s Masayoshi Son and OpenAI co-founder Sam Altman promised during a White House briefing ...
STAT8h
OpenAI leaps into health care with AI benchmark to evaluate models
OpenAI on Monday released a large dataset for evaluating how well large language models answer questions related to health ...
Cryptopolitan11h
SoftBank and OpenAI’s $100B AI gamble stalled by tariffs and market woes
SoftBank’s $100 billion AI project with OpenAI has stalled due to US tariffs and economic uncertainty. Investors are holding ...
OpenAI’s $3 Billion Windsurf Acquisition Changes AI Forever
OpenAI’s $3B Windsurf acquisition reshapes AI innovation, challenging Google and Anthropic in the race for artificial ...
OpenAI to Invest in Efforts to Build AI Infrastructure Overseas
OpenAI plans to invest in efforts outside of the US to develop the infrastructure necessary to run artificial intelligence ...
OpenAI CEO Sam Altman to testify before Senate committee on AI: 'Good will outweigh the bad'
OpenAI CEO Sam Altman will testify before the Senate Committee on Commerce, Science, and Transportation Thursday about the ...
OpenAI says its nonprofit will continue to control its business
OpenAI is reversing course and said Monday its nonprofit will continue to control the business that makes ChatGPT and other ...
OpenAI Backtracks on Plans to Drop Nonprofit Control
The company will become a public benefit corporation and the nonprofit that has controlled it will be its largest shareholder ...
OpenAI reverses course and says its nonprofit will continue to control its business
OpenAI is reversing course and said Monday its nonprofit will continue to control the business that makes ChatGPT and other ...
DMR News on MSN17h
OpenAI and FDA explore AI for speeding up drug evaluations
OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...